These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11331441)

  • 21. Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia.
    Almond CS; Harrington J; Thiagarajan R; Duncan CN; LaPierre R; Halwick D; Blume ED; Del Nido PJ; Neufeld EJ; McGowan FX
    J Heart Lung Transplant; 2006 Nov; 25(11):1376-9. PubMed ID: 17097505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
    Campbell KR; Mahaffey KW; Lewis BE; Weitz JI; Berkowitz SD; Ohman EM; Califf RM
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():14F-9. PubMed ID: 11156729
    [No Abstract]   [Full Text] [Related]  

  • 23. Direct thrombin inhibitors in acute coronary syndromes.
    Jang IK
    Lancet; 2002 Aug; 360(9331):491-2; author reply 492. PubMed ID: 12241752
    [No Abstract]   [Full Text] [Related]  

  • 24. Direct thrombin inhibitors (part 2 of 2).
    Arora UK; Dhir M
    J Invasive Cardiol; 2005 Feb; 17(2):85-91. PubMed ID: 15687531
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost analysis of bivalirudin in percutaneous coronary intervention.
    Lauer MA
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():37F-40. PubMed ID: 11156733
    [No Abstract]   [Full Text] [Related]  

  • 26. Advances in antithrombotic therapy: novel agents.
    Turpie AG; Weitz JI; Hirsh J
    Thromb Haemost; 1995 Jul; 74(1):565-71. PubMed ID: 8578525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic benefits and hemorrhagic risks of direct thrombin antagonists.
    Harker LA; Hanson SR; Kelly AB
    Thromb Haemost; 1995 Jul; 74(1):464-72. PubMed ID: 8578508
    [No Abstract]   [Full Text] [Related]  

  • 28. Building a stronger foundation: improved antithrombin therapy with bivalirudin in percutaneous coronary intervention.
    Knopf W
    J Invasive Cardiol; 2002 Apr; 14 Suppl B():1B. PubMed ID: 11967384
    [No Abstract]   [Full Text] [Related]  

  • 29. Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?
    Lincoff AM
    Am Heart J; 2003 Oct; 146(4 Suppl):S23-30. PubMed ID: 14564303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of bivalirudin in patients with renal impairment.
    Robson R
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():33F-6. PubMed ID: 11156732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hirudin and hirudin analogues as new anticoagulant agents.
    Pineo GF; Hull RD
    Curr Opin Hematol; 1995 Sep; 2(5):380-5. PubMed ID: 9372023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring of bivalirudin anticoagulation during and after cardiopulmonary bypass using an ecarin-activated TEG system.
    Koster A; Buz S; Krabatsch T; Dehmel F; Hetzer R; Kuppe H; Dyke C
    J Card Surg; 2008; 23(4):321-3. PubMed ID: 18482390
    [No Abstract]   [Full Text] [Related]  

  • 33. Beyond unfractionated heparin and warfarin: current and future advances.
    Hirsh J; O'Donnell M; Eikelboom JW
    Circulation; 2007 Jul; 116(5):552-60. PubMed ID: 17664384
    [No Abstract]   [Full Text] [Related]  

  • 34. Bivalirudin.
    Warkentin TE; Greinacher A; Koster A
    Thromb Haemost; 2008 May; 99(5):830-9. PubMed ID: 18449412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A second look at bivalirudin.
    Antman EM; Braunwald E
    Am Heart J; 2001 Dec; 142(6):929-31. PubMed ID: 11717592
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of platelet aggregation with eptifibatide, bivalirudin, and heparin in patients undergoing percutaneous coronary intervention receiving clopidogrel pretreatment (The PharmacoDynamic Evaluation of Angiomax, Clopidogrel with or without INtegrilin [DEACON] study).
    Saucedo JF; Aude W; Pacheco R; Thorn B; Matin Z; Husain K; Garza L
    Am J Cardiol; 2005 Jun; 95(12):1453-6. PubMed ID: 15950569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin?
    Seybert AL; Coons JC; Zerumsky K
    Pharmacotherapy; 2006 Feb; 26(2):229-41. PubMed ID: 16466327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absolute and relative truth in clinical trials.
    Julian D
    Lancet; 2002 Jun; 359(9321):1945-6; author reply 1946. PubMed ID: 12057577
    [No Abstract]   [Full Text] [Related]  

  • 39. Direct thrombin inhibition with bivalirudin as an antithrombotic strategy in general and interventional cardiology.
    Ahrens I; Smith BK; Bode C; Peter K
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):609-20. PubMed ID: 17696810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trials of conjunctive anticoagulant strategies in thrombolysis.
    Kleiman NS
    Coron Artery Dis; 1996 Jul; 7(7):508-15. PubMed ID: 8913678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.